PubRank

Joseph S Ross

Author PubWeight™ 178.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009 11.51
2 An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes 2008 6.00
3 Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 2013 5.27
4 The ADVANTAGE seeding trial: a review of internal documents. Ann Intern Med 2008 4.70
5 Regulatory review of novel therapeutics--comparison of three regulatory agencies. N Engl J Med 2012 4.50
6 Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 2010 4.36
7 Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA 2009 4.24
8 When choosing statin therapy: the case for generics. JAMA Intern Med 2013 3.80
9 Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 2011 3.48
10 Avoidance of generic competition by Abbott Laboratories' fenofibrate franchise. Arch Intern Med 2012 2.95
11 Use of fibrates in the United States and Canada. JAMA 2011 2.82
12 Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions. BMJ 2013 2.36
13 National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release. Circ Cardiovasc Qual Outcomes 2010 2.33
14 Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction. JAMA 2010 2.33
15 Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis. BMJ 2013 2.32
16 Sharing of clinical trial data among trialists: a cross sectional survey. BMJ 2012 2.31
17 Physician attitudes toward industry: a view across the specialties. Arch Surg 2010 2.29
18 Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. J Am Coll Cardiol 2010 2.26
19 Ghostwriting: research misconduct, plagiarism, or fool's gold? Am J Med 2012 2.19
20 Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA 2013 2.06
21 Advanced access scheduling outcomes: a systematic review. Arch Intern Med 2011 2.06
22 Recent trends in chronic disease, impairment and disability among older adults in the United States. BMC Geriatr 2011 2.02
23 Electronic health record components and the quality of care. Med Care 2008 1.97
24 Generic atorvastatin and health care costs. N Engl J Med 2011 1.95
25 What have we learnt from Vioxx? BMJ 2007 1.95
26 Comparison of hospital risk-standardized mortality rates calculated by using in-hospital and 30-day models: an observational study with implications for hospital profiling. Ann Intern Med 2012 1.90
27 Use of hospital-based acute care among patients recently discharged from the hospital. JAMA 2013 1.88
28 Use of ezetimibe in the United States and Canada. N Engl J Med 2008 1.85
29 Assessing the impact of screening colonoscopy on mortality in the medicare population. J Gen Intern Med 2011 1.73
30 Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009 1.69
31 Acute myocardial infarction and congestive heart failure outcomes at specialty cardiac hospitals. Circulation 2007 1.61
32 Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trial. Arch Intern Med 2011 1.60
33 The cost of breast cancer screening in the Medicare population. JAMA Intern Med 2013 1.53
34 Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: implications for regionalization. Arch Intern Med 2010 1.52
35 Tamiflu: 14 flu seasons and still questions. BMJ 2013 1.49
36 A historic moment for open science: the Yale University Open Data Access project and medtronic. Ann Intern Med 2013 1.45
37 Do imaging studies performed in physician offices increase downstream utilization?: an empiric analysis of cardiac stress testing with imaging. JACC Cardiovasc Imaging 2011 1.44
38 Evaluation of the Mobile Acute Care of the Elderly (MACE) service. JAMA Intern Med 2013 1.43
39 Relationships with the drug industry: More regulation, greater transparency. BMJ 2009 1.38
40 A model for dissemination and independent analysis of industry data. JAMA 2011 1.35
41 Influence of patients' socioeconomic status on clinical management decisions: a qualitative study. Ann Fam Med 2008 1.34
42 Pharmaceutical industry marketing: understanding its impact on women's health. Obstet Gynecol Surv 2008 1.21
43 Scheduled and unscheduled hospital readmissions among patients with diabetes. Am J Manag Care 2010 1.18
44 Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing. PLoS One 2011 1.16
45 Skilled nursing facility referral and hospital readmission rates after heart failure or myocardial infarction. Am J Med 2012 1.16
46 Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction. J Am Coll Cardiol 2008 1.14
47 Time to publication among completed clinical trials. JAMA Intern Med 2013 1.13
48 The relationship between systolic blood pressure on admission and mortality in older patients with heart failure. Eur J Heart Fail 2010 1.12
49 Sea change in open science and data sharing: leadership by industry. Circ Cardiovasc Qual Outcomes 2014 1.05
50 Development and use of an administrative claims measure for profiling hospital-wide performance on 30-day unplanned readmission. Ann Intern Med 2014 1.05
51 Beyond insurance coverage: usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey. Am Heart J 2010 1.03
52 What is different about the market for health care? JAMA 2007 1.01
53 Impact of state laws that extend eligibility for parents' health insurance coverage to young adults. Pediatrics 2012 1.01
54 The use and misuse of thrombolytic therapy within the Veterans Health Administration. Med Care 2012 1.00
55 Use of preventive care by elderly male veterans receiving care through the Veterans Health Administration, Medicare fee-for-service, and Medicare HMO plans. Am J Public Health 2007 1.00
56 Association of chronic diseases and impairments with disability in older adults: a decade of change? Med Care 2012 1.00
57 Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries. Arch Intern Med 2012 0.99
58 A measure of care coordination? J Gen Intern Med 2013 0.98
59 Persistence of cardiovascular risk after rofecoxib discontinuation. Arch Intern Med 2010 0.98
60 On Chlorofluorocarbon Bans and Inhaled Albuterol Prices. JAMA Intern Med 2015 0.96
61 The cost implications of prostate cancer screening in the Medicare population. Cancer 2013 0.95
62 Appropriate proton pump inhibitor use among older adults: a retrospective chart review. Am J Geriatr Pharmacother 2008 0.95
63 Financial stress and outcomes after acute myocardial infarction. PLoS One 2012 0.95
64 Hospital-based, acute care use among patients within 30 days of discharge after coronary artery bypass surgery. Ann Thorac Surg 2013 0.94
65 Audit and feedback: an intervention to improve discharge summary completion. J Hosp Med 2011 0.93
66 Association between physician quality improvement incentives and ambulatory quality measures. Am J Manag Care 2012 0.93
67 Is P4P really FFS? JAMA 2007 0.92
68 Description of a research-based health activism curriculum for medical students. J Gen Intern Med 2006 0.90
69 Visits for primary care services to primary care and specialty care physicians, 1999 and 2007. Arch Intern Med 2012 0.89
70 Usual source of care and outcomes following acute myocardial infarction. J Gen Intern Med 2014 0.89
71 Revisiting Essure--Toward Safe and Effective Sterilization. N Engl J Med 2015 0.88
72 Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer. Breast Cancer Res Treat 2013 0.87
73 Age-based and sex-based disparities in screening colonoscopy use among medicare beneficiaries. J Clin Gastroenterol 2013 0.87
74 High incarceration rates among black men enrolled in clinical studies may compromise ability to identify disparities. Health Aff (Millwood) 2014 0.87
75 Use of Medicare and Department of Veterans Affairs health care by veterans with dementia: a longitudinal analysis. J Am Geriatr Soc 2009 0.87
76 Direct-to-consumer television advertising: time to turn off the tube? J Gen Intern Med 2013 0.87
77 Marketing to physicians in a digital world. N Engl J Med 2014 0.86
78 Regional density of cardiologists and rates of mortality for acute myocardial infarction and heart failure. Circ Cardiovasc Qual Outcomes 2013 0.85
79 Prevalence of inadequate blood pressure control among veterans after acute ischemic stroke hospitalization: a retrospective cohort. Circ Cardiovasc Qual Outcomes 2011 0.85
80 Trial-results reporting and academic medical centers. N Engl J Med 2015 0.84
81 A random effects multinomial logit analysis of using Medicare and VA healthcare among veterans with dementia. Home Health Care Serv Q 2010 0.84
82 Reporting discrepancies between the clinicaltrials.gov results database and peer-reviewed publications. Ann Intern Med 2014 0.84
83 US cardiologist workforce from 1995 to 2007: modest growth, lasting geographic maldistribution especially in rural areas. Health Aff (Millwood) 2011 0.83
84 Updated estimates of pharmaceutical company payments to physicians in Vermont. JAMA 2008 0.83
85 Who is missing from the measures? Trends in the proportion and treatment of patients potentially excluded from publicly reported quality measures. Am Heart J 2010 0.83
86 Self-reported and actual beta-blocker prescribing for heart failure patients: physician predictors. PLoS One 2009 0.83
87 Laboratory test ordering at physician offices with and without on-site laboratories. J Gen Intern Med 2010 0.83
88 Preventive Care Quality of Medicare Accountable Care Organizations: Associations of Organizational Characteristics With Performance. Med Care 2016 0.83
89 Variation in US hospital emergency department admission rates by clinical condition. Med Care 2015 0.80
90 Hospital Use of Observation Stays: Cross-sectional Study of the Impact on Readmission Rates. Med Care 2016 0.79
91 Switching from rosiglitazone: thinking outside the class. JAMA 2011 0.79
92 Determinants of cardiac catheterization use in older Medicare patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2009 0.79
93 Cardiac Certificate of Need regulations and the availability and use of revascularization services. Am Heart J 2007 0.79
94 Risk-standardized Acute Admission Rates Among Patients With Diabetes and Heart Failure as a Measure of Quality of Accountable Care Organizations: Rationale, Methods, and Early Results. Med Care 2016 0.78
95 The importance of population-based performance measures. Health Serv Res 2007 0.78
96 Expanding the frontier of outcomes measurement for public reporting. Circ Cardiovasc Qual Outcomes 2011 0.78
97 Randomized clinical trials and observational studies are more often alike than unlike. JAMA Intern Med 2014 0.78
98 Global Drug Safety Insights From Taiwan. JAMA Intern Med 2015 0.77
99 Restricting interactions with industry to promote evidence-based prescribing. JAMA Intern Med 2014 0.77
100 Hospital discharge and the transition home for poor patients: "I knew I couldn't do what they were asking me". J Gen Intern Med 2014 0.77
101 Coronary artery bypass graft: contemporary heart surgery center performance in China. Circ Cardiovasc Qual Outcomes 2012 0.77
102 Therapeutic Substitution-Should It Be Systematic or Automatic? JAMA Intern Med 2016 0.76
103 Refusal of care by patients. JAMA 2006 0.75
104 Conflicts of interest, authorship, and disclosures in industry-related scientific publications. Mayo Clin Proc 2010 0.75
105 No Time to Wait. JAMA Intern Med 2015 0.75
106 Discharge disposition disagreements and re-admission risk among older adults: a retrospective cohort study. BMJ Open 2012 0.75
107 Insurance coverage and care of patients with non ST-segment elevation acute coronary syndromes. Ann Intern Med 2007 0.75
108 We can see the (risks of UV) light. JAMA Intern Med 2015 0.75
109 Making Data Submitted to the Food and Drug Administration More Visible. JAMA Intern Med 2016 0.75
110 Mis-SHAPEing public health policy. Circ Cardiovasc Qual Outcomes 2009 0.75
111 It's not just about the money, money, money…. JAMA Intern Med 2014 0.75
112 Through the looking glass: evaluating the dissemination of research in cardiology. Eur Heart J 2012 0.75
113 "Transparency reports" on industry payments to physicians and teaching hospitals. JAMA 2012 0.75
114 Informed Consent and Communicating Risk and Benefits of Research on Higher-Risk Medications. JAMA Intern Med 2015 0.75
115 Pediatric screening urinalysis: a difference-in-differences analysis of how a 2007 change in guidelines impacted use. BMC Pediatr 2014 0.75
116 High-Deductible Health Plans and Higher-Value Decisions: A Mirage or Are We Just Not There Yet? JAMA Intern Med 2016 0.75
117 A better pain plan. JAMA Intern Med 2015 0.75
118 Reply: To PMID 23303273. JAMA Intern Med 2013 0.75
119 Making Electronic Health Records Work Better for Patient Care. JAMA Intern Med 2016 0.75
120 Promoting Evidence-Based High-Value Health Care. JAMA Intern Med 2015 0.75
121 The physical activity contract--tailored to promote physical activity in a geriatric outpatient setting: a pilot study. J Am Geriatr Soc 2010 0.75
122 Moving forward from rhBMP-2: open science and data sharing. Spine (Phila Pa 1976) 2014 0.75
123 Economic evaluation of a comprehensive teenage pregnancy prevention program: pilot program. Am J Prev Med 2009 0.75
124 Strengthening Medical Device Postmarket Safety Surveillance. JAMA Intern Med 2015 0.75
125 Ensuring correct interpretation of diagnostic test results. JAMA Intern Med 2014 0.75
126 Confronting bias. JAMA Intern Med 2015 0.75
127 High-risk medical devices: why do we not better understand effectiveness and safety? JAMA Intern Med 2015 0.75
128 Would a Breakthrough Therapy by Any Other Name Be as Promising? JAMA Intern Med 2015 0.75
129 Observation encounters and subsequent nursing facility stays. Am J Manag Care 2015 0.75
130 Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline. J Am Coll Cardiol 2017 0.75
131 Quality of Care in the United States Territories, 1999-2012. Med Care 2017 0.75
132 Triage, Copayments, and Emergency Department Visits. JAMA Intern Med 2016 0.75
133 Merits of Data Sharing: The Digitalis Investigation Group Trial. J Am Coll Cardiol 2017 0.75
134 Quality of Care in the United States Territories, 1999-2012. Med Care 2017 0.75
135 Association of physician specialty and medical therapy for benign prostatic hyperplasia. Med Care 2014 0.75
136 Association between FDA black box warnings and Medicare formulary coverage changes. Am J Manag Care 2017 0.75
137 Generic competition in a flawed system: pill them, bill them-reply. Arch Intern Med 2012 0.75
138 Hospital Characteristics Associated With Risk-standardized Readmission Rates. Med Care 2017 0.75
139 Adoption of new agents and changes in treatment patterns for hepatitis C: 2010-2014. Am J Manag Care 2016 0.75
140 The cost of pharmaceutical innovation to patients. Expert Opin Drug Discov 2007 0.75